Related Experiment Video
Updated: May 23, 2026
14:14
Adaptation of Semiautomated Circulating Tumor Cell (CTC) Assays for Clinical and Preclinical Research Applications
Published on: February 28, 2014
Progress in circulating tumor cell capture and analysis: implications for cancer management
Marija Balic1, Henry Lin, Anthony Williams
1Division of Oncology, Department of Internal Medicine, Medical University of Graz, Auenbruggerplatz 15, 8036, Graz, Austria. marija.balic@medunigraz.at
Expert Review of Molecular Diagnostics
|April 4, 2012
Summary
Detecting circulating tumor cells (CTCs) shows promise as a biomarker for cancer metastasis and monitoring treatment response. Advances in CTC detection technologies are paving the way for wider clinical application in oncology.
Area of Science:
- Oncology
- Biomarkers
- Cancer Metastasis
Background:
- Hematogenous dissemination of cancer leading to distant metastases causes most cancer deaths.
- Circulating tumor cells (CTCs) are emerging as a key surrogate biomarker for metastasis.
- Growing interest exists in novel CTC detection technologies and their clinical significance.
Purpose of the Study:
- To review the progress of CTC detection methods.
- To assess the clinical importance and potential applications of CTCs.
- To speculate on future technological improvements and wider implementation in diagnostics and therapeutic monitoring.
Main Methods:
- Literature review and synthesis of current research on CTC detection technologies.
- Analysis of the prognostic relevance and utility of CTCs in clinical trials.
- Evaluation of evidence regarding CTCs in therapeutic response monitoring.
Main Results:
- Accumulating evidence supports the development of novel CTC detection technologies.
- CTCs are increasingly included in clinical trials, particularly for breast cancer.
- Significant potential exists for CTCs as a diagnostic tool and for monitoring treatment response.
Conclusions:
- CTCs hold considerable promise as a biomarker in oncology, especially for monitoring therapeutic response.
- Further technological advancements are expected to enhance the clinical utility of CTCs.
- Wider implementation of CTC detection is anticipated for improved cancer diagnostics and patient management.
